ASMLs, Earnings

ASML's Q2 Earnings: A Capacity Squeeze and a Political Cloud Test the AI Boom's Engine

Veröffentlicht: 15.07.2026 um 03:11 Uhr, Redaktion boerse-global.de

ASML reports Q2 earnings Wednesday with fully booked orders through 2027, but stock near 11% below high and new US export rules threaten 20% China revenue.

ASML Q2 Earnings: Full Order Book Through 2027 Amid US China Export Risks
ASML's Q2 Earnings: A Capacity Squeeze and a Political Cloud Test the AI Boom's Engine Illustration mit AI erstellt übermittelt durch boerse-global.de

Investors in ASML face a peculiar kind of tension as the Dutch lithography giant prepares to report second-quarter earnings on Wednesday. On one hand, the order book is effectively full through the end of 2027, with chipmakers scrambling to secure production slots for the most advanced machines. On the other hand, the stock sits nearly 11% below its all-time high, and a fresh wave of US regulatory scrutiny threatens to dampen the China-driven portion of its revenue.

The market's immediate focus, however, is on the quarterly numbers. Consensus estimates compiled by LSEG point to net income of €2.61bn to €2.64bn, an 8.8% year-on-year increase. Revenue is forecast to land between €8.4bn and €9.0bn, comfortably within the company's own guidance range of €36bn to €40bn for the full year. But the headline profit figure will take a back seat to order intake — the net new bookings that serve as a leading indicator of future revenue. Given the capacity constraints already flagged for 2027, analysts will parse this metric with unusual intensity.

Analyst optimism runs deep but not universal

The bullish camp has been vocal in recent weeks. Susquehanna's Mehdi Hosseini expects a clear beat-and-raise report, pointing to ASML's fully booked position through 2027 as evidence of demand that outstrips supply. Morningstar's Javier Correonero goes further, arguing that ASML's own 2030 revenue target of at least €44bn is too conservative; he models €60bn instead. ING's Marc Hesselink notes that ASML has underperformed the Philadelphia Semiconductor Index so far this year, and that a strong set of results combined with a capacity expansion could close that gap.

Bernstein has a price target of $2,623 on the stock, while J.P. Morgan maintains an Overweight rating with a $2,200 target, both citing the company's effective monopoly on extreme ultraviolet (EUV) lithography systems — the only machines capable of producing the world's most advanced chips. The stock closed on Tuesday at €1,556.40, giving a market capitalisation of roughly €605bn and making ASML Europe's most valuable listed company.

Should investors sell immediately? Or is it worth buying Asml?

Washington casts a long shadow over China revenue

Just one day before the earnings release, the geopolitical risk crystallised further. On 14 July, Jeffrey Kessler of the US Department of Commerce testified before the House Foreign Affairs Committee, pledging additional regulatory action on semiconductor and AI exports. While Kessler described current shipments of advanced AI chips to China as "trivial" and said strict licensing rules were effective, the proposed MATCH Act remains a live threat for ASML. The legislation specifically targets deep-ultraviolet (DUV) immersion lithography systems — the very technology that underpins the bulk of ASML's China business.

China is expected to account for roughly 20% of ASML's total revenue in 2026. Any additional export restrictions would directly jeopardise that contribution, cutting into the medium-term sales trajectory that management has laid out. The company's own guidance for 2026 revenue of €36bn–€40bn already assumes a degree of geopolitical friction; further tightening would force a downward revision.

Capacity expansion: more than just a numbers game

CEO Christophe Fouquet has made no secret of his determination to avoid repeating the supply-chain bottlenecks that plagued the industry during the pandemic. ASML plans to deliver 60 EUV machines this year and 80 next year, and the company believes that, with existing capacity, up to 90 units are theoretically possible. JPMorgan analysts think the ceiling could be as high as 110.

Beyond the sheer volume, ASML is exploring creative ways to stretch capacity: upgrades of older machines, faster assembly cycles, and more efficient installation processes. The company has also secured additional inventories of critical components — lenses and mirrors from Germany's Zeiss, and high-power lasers from Trumpf — to insulate supply chains from disruption. These measures are designed not only to satisfy immediate customer demand but to maintain the pricing power that comes from scarcity.

Customer momentum broadens beyond AI

The demand pull is no longer confined to the usual suspects. While SK Hynix, Samsung and Micron continue to expand their memory-chip capacity, and Taiwan Semiconductor Manufacturing (TSMC) remains the largest customer — fabricating chips for Nvidia — the landscape is widening. Intel's recovery efforts and Elon Musk's TeraFab ambitions could add a new layer of orders, further tightening the supply-demand balance.

Asml at a turning point? This analysis reveals what investors need to know now.

This week's earnings also carry a sector-wide weight. With tech shares in a jittery phase driven by fears of a rotation out of AI winners, the results from both TSMC and ASML will be seen as bellwethers. The options market is pricing a swing of roughly 7.5% in ASML's stock following the report, and the 30-day annualised volatility of 64.67% underscores the high stakes.

For now, the immediate question is whether ASML can deliver a beat-and-raise that satisfies the lofty expectations baked into its 58% year-to-date gain. But the longer-term challenge — balancing a capacity ceiling against geopolitical headwinds — will likely define the narrative long after Wednesday's numbers are digested.

Ad

Asml Stock: New Analysis - 15 July

Fresh Asml information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.

Read our updated Asml analysis...

Disclaimer zu unseren Artikeln: Keine Anlageberatung, keine Kauf oder Verkaufsempfehlung. Angaben zu Kursen, Unternehmen und Märkten ohne Gewähr; Änderungen jederzeit möglich. Börsengeschäfte können zu hohen Verlusten führen. Unsere Beiträge werden ganz oder teilweise automatisiert mit Unterstützung von AI erstellt und geprüft.

en | NL0010273215 | ASMLS | boerse | 69769746 |